Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for InspireMD (NSPR) over the last 14 years, with Q3 2025 value amounting to $5.4 million.

  • InspireMD's Accumulated Expenses rose 13170.42% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 13170.42%. This contributed to the annual value of $3.4 million for FY2024, which is 5603.29% up from last year.
  • As of Q3 2025, InspireMD's Accumulated Expenses stood at $5.4 million, which was up 13170.42% from $3.6 million recorded in Q2 2025.
  • In the past 5 years, InspireMD's Accumulated Expenses registered a high of $5.4 million during Q3 2025, and its lowest value of $906000.0 during Q1 2021.
  • For the 5-year period, InspireMD's Accumulated Expenses averaged around $1.9 million, with its median value being $1.6 million (2022).
  • In the last 5 years, InspireMD's Accumulated Expenses crashed by 1933.44% in 2021 and then soared by 13170.42% in 2025.
  • InspireMD's Accumulated Expenses (Quarter) stood at $1.5 million in 2021, then increased by 22.72% to $1.9 million in 2022, then increased by 18.08% to $2.2 million in 2023, then soared by 56.03% to $3.4 million in 2024, then skyrocketed by 56.91% to $5.4 million in 2025.
  • Its last three reported values are $5.4 million in Q3 2025, $3.6 million for Q2 2025, and $2.5 million during Q1 2025.